HomeBUSINESS
BUSINESS

Me Pharma Sees Opportunities in Low-Cost Strategy, Could Carve Out New Biz Models: President
(Aug.14.2017)

Me Pharma President Masaru Yoshida
While the Japanese generic market continues to grow on the back of the government’s push for its 80% share target, relentless pricing pressure and fierce competition are casting a shadow on the future of the industry. Me Pharma, a subsidiary of Meiji Seika Pharma launched in May, will put to the test a new business model where the company aims to rack up profits from low-cost generics for lifestyle disease treatments. President Masaru Yoshida sat with Jiho to talk about the company’s future outlook ...
(LOG IN FOR FULL STORY)

News Calendar